Deshpande, Pallavi OnkarBele, VivekJoshi, KedarThakurdesai, Prasad Arvind2020-10-162020-10-162020-01Deshpande Pallavi Onkar, Bele Vivek, Joshi Kedar, Thakurdesai Prasad Arvind. Effects of low molecular weight galactomannans based standardized fenugreek seed extract in subjects with high fat mass: A randomized, double-blind, placebo-controlled clinical study. Journal of Applied Pharmaceutical Science. 2020 Jan; 2020 Jan: 062-0692231-3354http://imsear.searo.who.int/handle/123456789/210745The present investigation evaluated the effects of low molecular weight galactomannans-based standardized fenugreekseeds extract (LMWGAL-TF) on human subjects with high-fat mass for 8-weeks using a prospective, randomized,double-blind, placebo-controlled design. Twenty-four subjects with percent body fat were randomized to ingest acapsule of LMWGAL-TF (500 mg, once a day) or the matching placebo at a 1:1 ratio for 8 weeks. The outcomemeasurements were recorded at baseline, week-4, and week-8 (end of the treatment). The efficacy outcome includedfat mass (absolute, non-fat mass and %) by skinfold thickness method (along with triceps, suprailiac, and abdominal)and bioelectrical impedance analysis method, body weight, body mass index, and abdominal girth. The standardsafety parameters were measured, such as adverse events, vital signs, hematology, and biochemistry. Eight weeksof LMWGAL-TF supplementation showed significant reduction in suprailiac skinfold thickness (v/s baseline) andabdominal skinfold thickness (v/s baseline and v/s placebo), and percent fat mass, (v/s baseline). The LMWGAL-TFsupplementation was found to be safe and well-tolerated. In conclusion, LMWGAL-TF supplementation showedsafety and efficacy in reducing skinfold thickness (abdominal and suprailiac) and percent body fat in subjects with ahigh fat massFenugreek seedlow molecular weight galactomannansfat massskinfold thicknessobesityEffects of low molecular weight galactomannans based standardized fenugreek seed extract in subjects with high fat mass: A randomized, double-blind, placebo-controlled clinical studyJournal ArticleIndiaIndus Biotech Private Limited, 1, Rahul Residency, Off Salunke Vihar Road, Kondhwa, Pune 411048, IndiaHanul Medizin (India) LLP, E 1, Kaul Building, 8 Gurunanak Nagar, Off Shankershet Road, Pune 411 042, India.Hanul Medizin (India) LLP, E 1, Kaul Building, 8 Gurunanak Nagar, Off Shankershet Road, Pune 411 042, IndiaIndus Biotech Private Limited, 1, Rahul Residency, Off Salunke Vihar Road, Kondhwa, Pune 411048, India